Use of soluble recombinant TNF receptor to improve detection of TNF secretion in cultures of tumor infiltrating lymphocytes

scientific article published on July 6, 1992

Use of soluble recombinant TNF receptor to improve detection of TNF secretion in cultures of tumor infiltrating lymphocytes is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/0022-1759(92)90112-7
P953full work available at URLhttps://api.elsevier.com/content/article/PII:0022175992901127?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:0022175992901127?httpAccept=text/plain
P698PubMed publication ID1321199

P50authorSteven RosenbergQ2347448
P2093author name stringC. A. Smith
S. A. Rosenberg
S. Schwarz
J. J. Mulé
M. Custer
P. Hwu
P2860cites workMolecular cloning and expression of a receptor for human tumor necrosis factorQ24303604
An endotoxin-induced serum factor that causes necrosis of tumorsQ24564406
Improved retroviral vectors for gene transfer and expressionQ29614384
Recombinant human tumor necrosis factor administered as a five-day continuous infusion in cancer patients: phase I toxicity and effects on lipid metabolismQ33450431
A phase I trial of intravenously-administered recombinant tumor necrosis factor-alpha in cancer patientsQ33451539
A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteinsQ33909940
Gene transfer into humans--immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transductionQ34354588
Partial purification of a serum factor that causes necrosis of tumorsQ35984071
Interferon gamma and tumor necrosis factor have a role in tumor regressions mediated by murine CD8+ tumor-infiltrating lymphocytesQ36230021
Intralesional application of recombinant human tumor necrosis factor alpha induces local tumor regression in patients with advanced malignanciesQ40778483
Phase I study of recombinant human tumor necrosis factor alpha in advanced malignant diseaseQ40779573
Recombinant Human Tumor Necrosis Factor Administered as a 24-Hour Intravenous Infusion. A Phase I and Pharmacologic StudyQ40783265
Optimal collection of blood samples for the measurement of tumor necrosis factor alphaQ41723874
Expansion of human tumor infiltrating lymphocytes for use in immunotherapy trialsQ44098509
Molecular cloning of the complementary DNA for human tumor necrosis factorQ48379825
EVIDENCE FOR TUMOUR NECROSIS FACTOR/CACHECTIN PRODUCTION IN CANCERQ61819299
Tumor localization of adoptively transferred indium-111 labeled tumor infiltrating lymphocytes in patients with metastatic melanomaQ69484555
Experience with the use of high-dose interleukin-2 in the treatment of 652 cancer patientsQ69548004
Studies on the anti-tumor efficacy of systemically administered recombinant tumor necrosis factor against several murine tumors in vivoQ69727000
Antitumor activity of murine tumor necrosis factor (TNF) against transplanted murine tumors and heterotransplanted human tumors in nude miceQ70589154
P433issue1-2
P407language of work or nameEnglishQ1860
P921main subjectTNFQ18032037
immunologyQ101929
P304page(s)139-147
P577publication date1992-07-01
1992-07-06
P1433published inJournal of Immunological MethodsQ15755939
P1476titleUse of soluble recombinant TNF receptor to improve detection of TNF secretion in cultures of tumor infiltrating lymphocytes
P478volume151

Reverse relations

cites work (P2860)
Q42811728A dual specificity promoter system combining cell cycle-regulated and tissue-specific transcriptional control
Q58377258The potential of serum levels of soluble tumour necrosis factor receptor I as a biochemical marker in cervical cancer

Search more.